Abstract
Few studies discuss the risk factors for acute cardiac lesions (within 30 days) resulting from Kawasaki disease (KD). We aimed to clarify the characteristics of patients with cardiac lesions within 30 days and determine the risk factors for acute cardiac lesion subtypes. Using the 23rd nationwide survey of KD in Japan, we analyzed data from patients with or without acute cardiac lesions resulting from KD (n = 31,380). We subdivided patients with acute cardiac lesions into three types: acute valvular lesions, coronary aneurysms, and giant coronary aneurysms (GCA), and calculated the odds ratios of potential risk factors for acute cardiac lesion subtypes. The prevalence of acute cardiac lesions was 8.6%, and these lesions were more prevalent among males than females (1.98:1). Male sex, age <1 year, and atypical definite cases predicted coronary artery lesions (CAL). The risk factors for valvular lesions differed from the risk factors for CALs, but GCA risk factors were similar to CAL risk factors: age <1 year, later presentation to hospital, atypical definite cases, and resistance to initial intravenous immunoglobulin (IVIG) therapy. Resistance to IVIG therapy was a significant risk factor for acute GCA. We found differences in cardiac lesion risk factors within 30 days of diagnosing KD between acute CAL and valvular lesions resulting from KD. In particular, pediatricians should consider atypical definite cases and resistance to initial IVIG when assessing the risk of acute-phase GCA.
Similar content being viewed by others
References
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110:2747–2771
Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Allergy 16:178–222
Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease—a 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385
Nakamura Y, Aso E, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, Ojima T, Yanagawa H, Kawasaki T (2005) Mortality among persons with a history of Kawasaki disease in Japan: can pediatricians safely discontinue follow-up of children with a history of the disease but without cardiac sequelae? Acta Paediatr 94:429–434
Nakamura Y, Aso E, Yashiro M, Uehara R, Watanabe M, Oki I, Yanagawa H (2008) Mortality among persons with a history of Kawasaki disease in Japan—mortality among males with cardiac sequelae is significantly higher than that of the general population. Circ J 72:134–138
Nakamura Y, Aso E, Yashiro M, Tsuboi S, Kojo T, Aoyama Y, Kotani K, Uehara R, Yanagawa H (2013) Mortality among Japanese with a history of Kawasaki disease: results at the end of 2009. J Epidemiol 23:429–434
Smith BA, Grider DJ (1993) Sudden death in a young adult: sequelae of childhood Kawasaki disease. Am J Emerg Med 11:381–383
Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP et al (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633–1639
Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, Kojo T, Uehara R, Kotani K, Yanagawa H (2015) Descriptive epidemiology of Kawasaki disease in Japan, 2011–2012: from the results of the 22nd nationwide survey. J Epidemiol 25(3):239–245
Nakamura Y, Fujita Y, Nagai M, Yanagawa H, Imada Y, Okawa S, Kawasaki T, Kato H (1991) Cardiac sequelae of Kawasaki disease in Japan: statistical analysis. Pediatrics 88:1144–1147
Zhang T, Yanagawa H, Oki I, Nakamura Y, Yashiro M, Tanihara S (1999) Factors related to cardiac sequelae of Kawasaki disease. Eur J Pediatr 158:694–697
Zhang T, Yanagawa H, Oki I, Nakamura Y (2002) Factors relating to the cardiac sequelae of Kawasaki disease one month after initial onset. Acta Paediatr 91:517–520
Kuwabara M, Yashiro M, Kotani K, Tsuboi S, Ae R, Nakamura Y, Yanagawa H, Kawasaki T (2015) Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan. J Epidemiol 25:189–193
Nakamura Y, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, Ojima T, Yanagawa H (2003) Case–control study of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 45:410–413
Sudo D, Monobe Y, Yashiro M, Sadakane A, Uehara R, Nakamura Y (2010) Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey. Pediatr Int 52:790–794
Maric LS, Knezovic I, Papic N, Mise B, Roglic S, Markovinovic L, Tesovic G (2015) Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience. Rheumatol Int 35:1053–1058
Ha KS, Jang G, Lee J, Lee K, Hong Y, Son C (2013) Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis. Eur J Pediatr 172:343–349
Lin MT, Sun LC, Wu ET, Wang JK, Lue HC, Wu MH (2015) Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous gamma-immunoglobulin therapy. Arch Dis Child 100:542–547
Ram Krishna M, Sundaram B, Dhanalakshmi K (2014) Predictors of coronary artery aneurysms in Kawasaki disease. Clin Pediatr 53:561–565
Akagi T, Rose V, Benson LN, Newman A, Freedom RM (1992) Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr 121:689–694
Nakamura Y, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, Ojima T, Sonobe T, Yanagawa H (2004) Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 46:33–38
Chiang CY, Ho CH, Chu CC, Chen ZC, Wang IJ, Tseng YZ (2013) Coronary artery complications in pediatric patients with kawasaki disease: a 12-year national survey. Acta Cardiol Sin 29:357–365
Patel AS, Bruce M, Harrington W, Portman MA (2015) Coronary artery stenosis risk and time course in Kawasaki disease patients: experience at a US tertiary pediatric centre. Open Heart 2:e000206
Lee IR, Park S, Oh J, Jang G, Kim U, Kim K (2015) Hyponatremia may reflect severe inflammation in children with kawasaki disease. Child Kidney Dis 19:159–166
Acknowledgements
The authors would like to thank Drs. Jane Charbonneau and Angela Morben from Edanz Editing, who provided professional services.
Funding
The nationwide surveys of Kawasaki disease are partly financially supported by a research fund of the non-profit organization of Japan Kawasaki Disease Research Center.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There are no other conflicts of interest in this study.
Rights and permissions
About this article
Cite this article
Yamashita, M., Ae, R., Yashiro, M. et al. Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease. Pediatr Cardiol 38, 375–380 (2017). https://doi.org/10.1007/s00246-016-1525-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-016-1525-1